TrialBlood cancer journal2021

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.

Marc-Andrea Baertsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.